Tag Archives: Radiopharmaceuticals/pharmacokinetics

Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist

Xu J, Vangveravong S, Li S, Fan J, Jones LA, Cui J, Wang R, Tu Z, Chu W, Perlmutter JS, Mach RH. Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist. Neuroimage. May 2013;71:168-174. Full Text – Open Access Publication Date May 2013 How Analyze was Used…

The biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 18F-AH111585 in healthy volunteers

McParland BJ, Miller MP, Spinks TJ, Kenny LM, Osman S, Khela MK, Aboagye E, Coombes RC, Hui AM, Cohen PS. The biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 18F-AH111585 in healthy volunteers. J Nucl Med. October 2008;49(10):1664-1667. Full Text – Open Access Publication Date October 2008 How Analyze was Used “ROIs were defined on…

3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography

Barthel H, Cleij MC, Collingridge DR, Hutchinson OC, Osman S, He Q, Luthra SK, Brady F, Price PM, Aboagye EO. 3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res. July 2003;63(13):3791-3798. Full Text – Open Access Publication Date July 2003 How Analyze was Used…

Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F]FDG PET studies

Nofzinger EA, Nichols TE, Meltzer CC, Price J, Steppe DA, Miewald JM, Kupfer DJ, Moore RY. Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F]FDG PET studies. Psychiatry Res. August 1999;91(2):59-78. Publication Date August 1999 How Analyze was Used “The MR data were cropped in preparation for alignment with…